Accueil > Actualité
Actualite financiere : Actualite bourse

Roche: immunotherapies show promises in lymphoma

( - Roche said that it was "encouraged" by early results of two new investigational cancer immunotherapies, which may help people with difficult-to-treat lymphomas.

Results showed encouraging efficacy with an objective response rate of 62.7% in slow-growing relapsed or refractory (R/R) B-cell non-Hodgkin lymphoma and 37.1% in aggressive non-Hodgkin lymphoma.

In addition, data demonstrated a complete response rate of 43.3% in slow-growing non-Hodgkin lymphoma and 19.4% in aggressive non-Hodgkin lymphoma.

Copyright (c) 2019 All rights reserved.




Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.
Indices et cours différés d’au moins 15 mn | Cotations boursières fournies par ABC Bourse.